期刊文献+

The risk of cardiovascular events in patients with subclinical hypothyroidism: An updated meta-analysis based on 53813 participants

The risk of cardiovascular events in patients with subclinical hypothyroidism:An updated meta-analysis based on 53813 participants
原文传递
导出
摘要 Background Subclinical hypothyroidism is a metabolism disease with elevated thyroid stimulating hormone (TSH) and normal thyroid hormone levels. Patients with subclinical hypothyroidism can have abnormal lipid metabolism, hypertension, coagulation dysfunction, vascular endothelial dysfunction. However, the relationship between subclinical hypothyroidism and cardiovascular events is still uncertain. Methods Prospective studies on the association between subclinical hypothyroidism and coronary heart disease were searched in PubMed, Embase, Wanfang databases and the Cochrane Library. The incidences of coronary heart disease, cardiac death, heart failure and all-cause death were compared between subclinical hypothyroidism group and euthyroidism group. Odds ratios (ORs) with 95% confidence intervals (95% CIs) were used as summary statistics. Results Thirteen eligible studies incorporating 53813 participants were included in this recta-analysis. No significant dif- ferences were found in the comparison of the risk of CHD (9.67% vs. 7.74%, OR=1.09, P=0.19), cardiac death (7.80% vs. 4.74%, OR=1.34, P=0.06), all-cause death (13.26% vs. 13.63%, OR=l.05, P=0.77) and heart failure (7.12% vs. 4.29%, OR=1.24, P=0.22) between the subclinical hypothyroidism group and euthyroidism group. Conclusions Our results indicate that subclinical hypothyroidism might not increase the risk of cardio- vascular disease. Background Subclinical hypothyroidism is a metabolism disease with elevated thyroid stimulating hormone (TSH) and normal thyroid hormone levels. Patients with subclinical hypothyroidism can have abnormal lipid metabolism, hypertension, coagulation dysfunction, vascular endothelial dysfunction. However, the relationship between subclinical hypothyroidism and cardiovascular events is still uncertain. Methods Prospective studies on the association between subclinical hypothyroidism and coronary heart disease were searched in PubMed, Embase, Wanfang databases and the Cochrane Library. The incidences of coronary heart disease, cardiac death, heart failure and all-cause death were compared between subclinical hypothyroidism group and euthyroidism group. Odds ratios (ORs) with 95% confidence intervals (95% CIs) were used as summary statistics. Results Thirteen eligible studies incorporating 53813 participants were included in this recta-analysis. No significant dif- ferences were found in the comparison of the risk of CHD (9.67% vs. 7.74%, OR=1.09, P=0.19), cardiac death (7.80% vs. 4.74%, OR=1.34, P=0.06), all-cause death (13.26% vs. 13.63%, OR=l.05, P=0.77) and heart failure (7.12% vs. 4.29%, OR=1.24, P=0.22) between the subclinical hypothyroidism group and euthyroidism group. Conclusions Our results indicate that subclinical hypothyroidism might not increase the risk of cardio- vascular disease.
出处 《South China Journal of Cardiology》 CAS 2017年第1期21-31,共11页 岭南心血管病杂志(英文版)
关键词 subclinical hypothyroidism cardiovascular disease cardiac death thyroid-stimulating hormone subclinical hypothyroidism cardiovascular disease cardiac death thyroid-stimulating hormone
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部